Shelton Capital Management Integra Lifesciences Holdings Corp Transaction History

Shelton Capital Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $155,480 - $216,058	3,687 New	3,687 $206,000
Q4 2020 Feb 16, 2021	SELL	$43.31 - $66.55 $14,768 - $22,693	-341 Reduced 7.94%	3,953 $257,000
Q2 2020 Aug 12, 2020	SELL	$41.42 - $55.57 $9,650 - $12,947	-233 Reduced 5.15%	4,294 $202,000
Q1 2020 May 13, 2020	SELL	$36.67 - $61.04 $7,334 - $12,208	-200 Reduced 4.23%	4,527 $202,000
Q3 2019 Nov 13, 2019	SELL	$53.29 - $64.59 $17,319 - $20,991	-325 Reduced 6.43%	4,727 $284,000
Q2 2019 Aug 14, 2019	BUY	$46.45 - $55.85 $221,612 - $266,460	4,771 Added 1697.86%	5,052 $282,000
Q1 2019 May 10, 2019	SELL	$42.97 - $57.33 $205,009 - $273,521	-4,771 Reduced 94.44%	281 $5.05 Million
Q3 2018 Nov 14, 2018	BUY	$57.63 - $65.87 $291,146 - $332,775	5,052 New	5,052 $333,000
Q2 2018 Aug 10, 2018	SELL	$54.05 - $67.23 $334,137 - $415,615	-6,182 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$46.55 - $57.38 $34,959 - $43,092	751 Added 13.83%	6,182 $342,000
Q3 2017 Nov 28, 2017	BUY	$47.8 - $53.63 $259,601 - $291,264	5,431 New	5,431 $274,000
Q3 2017 Nov 14, 2017	SELL	$47.8 - $53.63 $283,836 - $318,454	-5,938 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	371 Added 6.66%	5,938 $324,000
Q1 2017 Nov 28, 2017	BUY	N/A	3,147 Added 130.04%	5,567 $235,000
Q3 2016 Dec 04, 2017	BUY	N/A	2,420	2,420 $208,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.